Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Axsome Therapeutics Inc buy BiotechBee

Start price
€81.00
24.06.23 / 60%
Target price
€100.00
31.12.25
Performance (%)
-14.20%
Price
€69.50
03.05.24
Summary
This prediction is currently active. The price of Axsome Therapeutics Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -14.20%. This prediction currently runs until 31.12.25. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 60% into this prediction
Performance without dividends (%)
Name 1w 1m
Axsome Therapeutics Inc 3.639% 3.639%
iShares Core DAX® -0.922% -1.078%
iShares Nasdaq 100 0.371% -0.556%
iShares Nikkei 225® 2.224% -2.825%
iShares S&P 500 -0.026% -0.788%

According to BiotechBee what are the pros and cons of Axsome Therapeutics Inc for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Axsome Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) -14.20%
Target price 100.000
Change
Ends at 31.12.25

Buy mit Kursziel 100,0

Stopped prediction by BiotechBee for Axsome Therapeutics Inc

buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€60.00
08.09.22
€80.00
31.12.24
35.00%
24.06.23

Could be very worthwhile Investment >20% year